Ethanol extract of Butea monosperma bark modulates dyslipidemia in streptozotocin-induced diabetic rats

Pharmaceutical Biology

Volumn 52, Issue 8, 2014, Pages 1021-1027

  Divya, B T ^a   Mini, S ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Butea monosperma; Diabetes mellitus; Dyslipidemia; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BUTEA MONOSPERMA EXTRACT; CHOLESTEROL; FLAVANOID; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; ISOCITRATE DEHYDROGENASE; MALATE DEHYDROGENASE (DECARBOXYLATING); PHENOL; PHYTOSTEROL; PLANT EXTRACT; SAPONIN; TANNIN DERIVATIVE; TERPENOID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; STREPTOZOCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARK; BUTEA MONOSPERMA; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES INDUCED DYSLIPIDEMIA; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DYSLIPIDEMIA; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPOLIPIDEMIC ACTIVITY; INSULIN BLOOD LEVEL; LIVER FUNCTION TEST; MALE; NONHUMAN; PHYTOCHEMISTRY; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; BUTEA; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; BUTEA; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; ETHANOL; HYPOGLYCEMIC AGENTS; MALE; PLANT BARK; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84904344016     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.876055     Document Type: Article

References (41)

1. Amos AF, McCarty DJ, Zimmet P. (1997). The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 14:S1-85.
2. Babu PS, Srivivasan K. (1997). Hypolipidemic action of curcumin, the active principle of turmeric in streptozotocin induced diabetic rats. Mol Cell Biochem 166:169-75.
3. Barneo L, Esteban MM, Garcia Pravia C, et al. (1990). Normalization of altered liver function tests after islet transplantation in diabetic rats. Diabet Metab 16:284-9.
4. Betteridge J. (1997). Lipid disorders in diabetes mellitus. In: Pickup JC, Williams G, eds. Textbook of Diabetes. London: Blackwell Science, 1-35.
5. Bhandari U, Kanojia R, Pillai KK. (2005). Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97:227-30.
6. Chattopadhyaya R, Pathak D, Jindal DP. (1996). Antihyperlipidemic agents. A review. Indian Drugs 33:85-97.
7. Dirican M, Serdar Z, Sarandol E, Gur ES. (2003). Lecithin: Cholesterol acyltransferase activity and cholesteryl ester transfer rate in patients with diabetes mellitus. Turk J Med Sci 33:95-101.
8. Divya BT, Mini S. (2011). In vitro radical scavenging activity of different extracts of Butea monosperma bark. Int J Curr Pharm Res 3: 114-16.
9. Ercyias F, Taneli F, Arslan B, Uslu Y. (2004). Glycemic control, oxidative stress and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 35:134-40.
10. Farmer JA. (1998). Aggressive lipid therapy in the statin era. Prog Cardiovasc Dis 41:71-94.
11. Ferner RE, Neil HAW. (1988). Sulphonylureas and hypoglycemia. Br Med J 296:949-50.
12. Franceschini G, Maderna P, Sirtori CR. (1991). Reverse cholesterol transport: Physiology and pharmacology. Atherosclerosis 88:99-107.
13. George F, Zohar K, Harinder PS, Makkar Klaus B. (2002). The biological action of saponins in animal systems: A review. Br J Nutr 88:587-605.
14. Gomes A, Vedasiromoni JR, Das M, et al. (2001). Antihyperglycemic effect of black tea (Camellia sinensis) in rat. J Ethnopharmacol 27: 243-75.
15. Haffner SM, Lehtos S, Ronnemaa T, et al. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-34.
16. Kannel WB, McGee DL. (1979). Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035-8.
17. Kim SH, Hyun SH, Choung SY. (2006). Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 104: 119-23.
18. Koh HJ, Lee SM, Son BG, et al. (2004). Cytosolic NAD+ dependent isocitrate dehydrogenase plays a role in lipid metabolism. Biol Chem 279:19968-74.
19. Kornberg A, Horecker CB. (1955). Glucose-6-phosphate dehydrogenase. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 323-7.
20. Lowry OH, Roesborough MJ, Farr AL, Randall RJ. (1951). Protein measurement with Folin's phenol reagent. J Biol Chem 193:265-75.
21. Mengi SA, Deshpande SG. (1999). Anti-inflammatory activity of Butea frondosa leaves. Fitoterapia 70:521-2.
22. Mooradian AD, Wong NCW, Shah GN. (1997). Apolipoprotein A1 expression in young and aged rats is modulated by dietary carbohydrates. Metabolism 46:1132-6.
23. Ochoa S. (1955). Malic enzyme. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 739-53.
24. Ochoa S. (1955). Isocitric dehydrogenase system (TPN) from pig heart. In: Colowick SP, Kaplan NO, eds. Methods in Enzymology. New York: Academic Press, 699-700.
25. Patil MV, Pawar S, Patil DA. (2006). Ethnobotany of Butea monosperma (Lam) Kuntze in North Maharashtra, India. Nat Prod Rad 5:323-5.
26. Pupim LB, Heimburger Q, Qureshi AR, et al. (2005). Accelerated lean body mass loss in incident chronic dialysis patients with diabetic mellitus. Kidney Int 68:2368-74.
27. Rao AV, Ramakrishnan S. (1975). Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue. Clin Chem 21:1523-5.
28. Salimuddin, Upadhyaya KC, Baquer NZ. (1999). Effects of vanadate on expression of liver arginase in experimental diabetic rats. IUBMB 48: 237-40.
29. Sambaiah K, Satyanarayana MN. (1982). Influence of red pepper and capsaicin on body composition and lipogenesis in rats. J Biosci 4: 425-30.
30. Saravanan R, Rajendra Prasad N, Pugalandi KV. (2003). Effect of Piper beetle leaf extract on alcoholic toxicity in the rat brain. J Med Food 6: 261-5.
31. Scalbert A, Johnson IT, Saltmarsh M. (2005). Polyphenols: Antioxidants and beyond. Am J Clin Nutr 81:S215-17.
32. Sharma AK, Deshwal N. (2011). An overview: On phytochemical and pharmacological studies of Butea monosperma. Int J Pharm Tech Res 3:864-71.
33. Shirwaikar A, Rajendra K, Kumar CD, Bodla R. (2004). Antidiabetic activity of aqueous leaf extracts of Annona squamosa in streptozotocin- nicotinamide type 2 diabetic rats. J Ethnopharmacol 91:171-5.
34. Sofowora H. (1993). Screening plants for bioactive agents. In: Medicinal Plants and Traditional Medicine in Africa. Ibadan, Nigeria: Spectrum Books Ltd, Sunshine House, 134-56.
35. Solymoss BC, Marcil M, Chasur M, et al. (1995). Fasting hyperinsulinism, insulin resistance syndrome, and coronary heart disease in men and women. Am J Cardiol 76:1152-6.
36. Somani R, Kasture S, Singhai AK. (2006). Antidiabetic potential of Butea monosperma in rats. Fitoterapia 77:86-90.
37. Suba V, Murugesan T, Rao RB, et al. (2004). Antidiabetic potential of Barleria lupulina extract in rats. Fitoterapia 75:1-4.
38. Tan BK, Tan CH, Pushparaj PN. (2005). Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed streptozotocin-induced diabetic rats. Life Sci 76:2827-39.
39. Thompson Coon JS, Ernst E. (2003). Herbs for serum cholesterol reduction: A systematic view. J Fam Pract 52:468-78.
40. Trease GE, Evans WC. (2002). Pharmacology. London: Saunders Publishers, 42-4, 221-9, 246-9, 303-6, 331-2, 391-3.
41. Wagman AS, Nuss JM. (2001). Current therapies and emerging targets for the treatment of diabetes. Curr Pharm Des 7:417-50.